首页> 外文期刊>Journal of Radiation Research: Official Organ of the Japan Radiation Research Society >Comparison of dose-volume histograms between proton beam and X-ray conformal radiotherapy for locally advanced non-small-cell lung cancer
【24h】

Comparison of dose-volume histograms between proton beam and X-ray conformal radiotherapy for locally advanced non-small-cell lung cancer

机译:质子束与X射线适形放疗在局部晚期非小细胞肺癌中剂量-体积直方图的比较

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was to compare the parameters of the dose-volume histogram (DVH) between proton beam therapy (PBT) and X-ray conformal radiotherapy (XCRT) for locally advanced non-small-cell lung cancer (NSCLC), according to the tumor conditions. A total of 35 patients having NSCLC treated with PBT were enrolled in this analysis. The numbers of TNM stage and lymph node status were IIB (n = 3), IIIA (n = 15) and IIIB (n = 17), and N0 (n = 2), N1 (n = 4), N2 (n = 17) and N3 (n = 12), respectively. Plans for XCRT were simulated based on the same CT, and the same clinical target volume (CTV) was used based on the actual PBT plan. The treatment dose was 74 Gy-equivalent dose (GyE) for the primary site and 66 GyE for positive lymph nodes. The parameters were then calculated according to the normal lung dose, and the irradiation volumes of the doses (Vx) were compared. We also evaluated the feasibility of both plans according to criteria: V5 >= 42%, V20 >= 25%, mean lung dose >= 20 Gy. The mean normal lung dose and V5 to V50 were significantly lower in PBT than in XCRT. The differences were greater with the more advanced nodal status and with the larger CTV. Furthermore, 45.7% of the X-ray plans were classified as inadequate according to the criteria, whereas 17.1% of the proton plans were considered unsuitable. The number of inadequate X-ray plans increased in cases with advanced nodal stage. This study indicated that some patients who cannot receive photon radiotherapy may be able to be treated using PBT.
机译:这项研究的目的是比较质子束治疗(PBT)和X射线适形放疗(XCRT)对局部晚期非小细胞肺癌(NSCLC)的剂量-体积直方图(DVH)参数,肿瘤情况。本研究共纳入35例接受PBT治疗的NSCLC患者。 TNM分期和淋巴结状态的数量分别为IIB(n = 3),IIIA(n = 15)和IIIB(n = 17),以及N0(n = 2),N1(n = 4),N2(n = 17)和N3(n = 12)。基于相同的CT模拟XCRT计划,并基于实际的PBT计划使用相同的临床目标体积(CTV)。对于主要部位,治疗剂量为74 GyE等效剂量;对于阳性淋巴结,治疗剂量为66 GyE。然后根据正常肺部剂量计算参数,并比较剂量的辐照量(Vx)。我们还根据以下标准评估了这两个计划的可行性:V5> = 42%,V20> = 25%,平均肺部剂量> = 20 Gy。 PBT的平均正常肺剂量和V5至V50显着低于XCRT。随着节点状态的提高和CTV的增大,差异更大。此外,根据标准,有45.7%的X射线图被归为不适当,而质子图的17.1%被认为是不合适的。在结节晚期的病例中,X线计划不充分的数量增加了。这项研究表明,某些无法接受光子放射治疗的患者可以使用PBT进行治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号